Stock listing
Matricelf Ltd.
Selected listing: MTRLF · OTC · USD · US
Matricelf Ltd. (OTC:MTRLF), Health Technology. Latest release Sep 3, 2026: Matricelf Receives FDA Feedback Supporting Key Elements of Proposed First in Human…
- Ticker
- OTC:MTRLF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Latest news from Matricelf Ltd.
Matricelf Receives FDA Feedback Supporting Key Elements of Proposed First in Human Clinical Trial for NewRal Spinal Cord Injury Program
September 3, 2026
Matricelf Continues Clinical Execution with Patient Enrollment Preparation Following GLP Safety Success and GMP Manufacturing Milestones
July 9, 2026
Matricelf Initiates IND Enabling Efficacy Study Following Positive Preclinical Results in Spinal Cord Injury
June 22, 2026
Matricelf Advances Toward First in Human Trial Following Successful GLP Safety Study Completion
June 17, 2026
Matricelf Enters Strategic Collaboration with Japan's CiRA Foundation to Advance Next-Generation Regenerative Manufacturing
March 30, 2026